GP-30101
- Generic Name
- GP-30101
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Geropharm
- Target Recruit Count
- 44
- Registration Number
- NCT04268472
- Locations
- 🇷🇺
Yarosslavl Clinical Hospital #3, Yaroslavl, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath